February 23rd 2023
February 23rd 2023
AJMC Panel Asks: Does it Pay to Use Pathways?
August 21st 2014Panel Discussion led by Seema Sonnad,PhD, that saw participation from ASCO's president Peter Paul Yu, MD; Jennifer Malin, MD, PhD, from WellPoint; Chadi Nabhan, MD, FACP, from the University of Chicago; and I.W. Tischler, MD, from Cigna.
Read More
Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice
The authors found no consistent pattern in the concordance between CER evidence and subsequent utilization patterns.
Read More
Clinical Pathway Adherence and Barriers to Coverage
June 2nd 2014The health services research poster session held in the afternoon on the penultimate day of the 50th annual meeting of the American Society of Clinical Oncology (ASCO) presented different perspectives on issues that determine patient care decisions. This is an important discussion, especially in light of the recent report by The Wall Street Journal on WellPoint's effort to promote oncologist adherence to standardized treatment guidelines.
Read More
Are Oncology Clinical Pathways Coming to Medicare?
February 14th 2014Oncology clinical pathways have helped health plans deliver quality care while keeping an eye on costs. The lack of standardization in pathways can be cumbersome on a busy oncology practice. If Medicare adopts a pathways model, it could offer a framework for broader use.
Read More